Labs / Assays & in vitro testing
Epsilogen
London, United Kingdom · epsilogen.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Epsilogen is a clinical-stage antibody therapeutics company focused on oncology. It develops IgE, IgA and IgG-based therapeutics and is based in London, with a US office in Boston.
They take quote requests by email.
What they offer
Discovery and development of IgE therapeutics
Develops IgE-based antibody therapeutics for cancer, including lead clinical candidate MOv18 IgE.
Discovery and development of IgA therapeutics
Develops IgA-based antibody therapeutics for oncology applications.
Discovery and development of IgG therapeutics
Develops IgG-based antibody therapeutics as part of its pan-isotype platform.
Bispecific antibody platform development
Creates bispecific IgE and IgEG antibodies based on its isotype expertise.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, Cell therapy
- Therapeutic areas
- oncology, ovarian cancer, platinum-resistant ovarian cancer
- Sites
- London, UK · Boston, USA
- Address
- 53 State Street Suite 500, Boston, MA, 02109
- Founded
- 2014
Similar labs. Evotec, Allumiqs, Aurigene Pharmaceutical Services, Avance Biosciences
Found in a contract services directory. Listing built from epsilogen.com. Work here? Claim this listing.